Cited by 308Obstructive Sleep Apnea ResearchSleep and related disordersRespiratory Support and Mechanisms

Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome

Open access
Engleman, H. M, Martin, S. E, Kingshott, R. N, Mackay, T. W, Deary, I. J, Douglas, N. J·1998·Thorax

Abstract

BACKGROUND: Patients with the sleep apnoea/hypopnoea syndrome (SAHS) report improved sleepiness, cognitive function, and psychological well being after continuous positive airway pressure (CPAP) therapy, and it is for these daytime features that CPAP is usually given. However, few randomised or controlled studies exist on the effects of CPAP on daytime function. METHODS: A prospective, randomised, single blind, placebo controlled, crossover trial of daytime function after CPAP was conducted in 23 patients with SAHS, all with > or = 15 apnoeas + hypopnoeas/hour and > or = 2 symptoms of SAHS. All patients spent four weeks on CPAP therapy and four weeks on oral placebo treatment, following randomisation to treatment order. With ethics committee approval, patients were told the placebo tablet might improve upper airway function. Average effective CPAP use was monitored using hidden time clocks. Assessments of objective and subjective sleepiness, symptoms, cognitive performance, and psychological well being were performed on the last day of each treatment and compared. RESULTS: Objective sleepiness measured by sleep onset latency on the multiple sleep latency test improved with CPAP (mean difference from placebo +2.4 min, 95% CI 0.8 to 4.0; p < 0.001) as did subjective sleepiness on the Epworth scale (mean difference -6, 95% CI -3 to -9; p = 0.001). Symptom total score also fell with CPAP (mean difference -1.6, 95% CI -2.2 to -1.0; p < 0.001). No determinants of these changes with active treatment were identified, and no significant enhancements to cognitive function or psychosocial well being were found in this small sample. CONCLUSIONS: These findings provide further evidence for clinically significant benefits to daytime function from CPAP.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/thx.53.5.341

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [13]13. US Modafinil in Narcolepsy Multicenter Study Group. Modafinil for the treatment of pathological somnolence in narcolepsy. Neurology 1998 (in press).
  2. [14]14. Australian Health Technology Advisory Committee. The eVectiveness and cost-eVectiveness of nasal continuous positive airway pressure (nCPAP) in the treatment of obstructive sleep apnea in adults. Canberra: Australian Government Publish- ing Services, 1996. on July 17, 2023 by guest. Protected by copyright. http://thorax.bmj.com/ Thorax: first published as 10.1136/thx.53.5.341 on 1 May 1998. Downloaded from

Cited by

Sorted by citations

Authors
Engleman, H. M., Martin, S. E., Kingshott, R. N., Mackay, T. W., Deary, I. J., & Douglas, N. J.
Affiliations
University of Edinburgh (GB)
Corresponding author
Douglas, N. J
Venue
Thorax
Publisher
BMJ
Published
1998-05-01
Volume
53
Issue
5
Pages
341-345
ISSN
0040-6376 (ISSN-L)
OpenAlex
W2123641217
Cited by
308
References
19
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 6 · 2021: 6 · 2020: 11 · 2019: 6 · 2018: 7 · 2017: 9 · 2016: 16 · 2015: 10 · 2014: 17 · 2013: 17 · 2012: 6
FWCI
7.35
Type
journal article
Language
en
Open access
Locations
  • Thorax (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
Keywords
sleep apnea-hypopnea syndrome, continuous positive airway pressure, CPAP therapy, daytime functioning, daytime sleepiness, cognitive function, psychological well-being, multiple sleep latency test, Epworth scale, symptom scores, placebo therapy, upper airway function
MeSH terms
Adult, Cognition, Female, Humans, Male, Middle Aged, Positive-Pressure Respiration, Prospective Studies, Quality of Life, Sleep Apnea Syndromes, Sleep Stages, Single-Blind Method, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review